Patent · US Active

Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine

US9784730B2 · kind B2 · utility

0Cited by

11References

19Claims

0Family size

Assignee

University of Washington through its Center for Commercialization · US

Inventors

Miqin Zhang · Bothell, US
Richard G. Ellenbogen · Seattle, US
Forrest Kievit · Seattle, US
John R. Silber · Seattle, US
Zachary Stephen · Seattle, US
Omid Veiseh · Bellaire, US

Key dates

Filing date	Mar 21, 2014
Grant date	Oct 10, 2017
Priority date	—
Expiry date	Aug 16, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Nanoparticle having a crosslinked chitosan-polyethylene oxide oligomer copolymer coating to which O6-benzylguanine is covalently coupled, compositions that include the nanoparticle, and methods for using the nanoparticle to treat brain cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.